Literature DB >> 27759153

The master Greatwall kinase, a critical regulator of mitosis and meiosis.

Suzanne Vigneron1, Perle Robert, Khaled Hached, Lena Sundermann, Sophie Charrasse, Jean-Claude Labbé, Anna Castro, Thierry Lorca.   

Abstract

Entry into mitosis requires the coordinated activation of various protein kinases and phosphatases that together activate sequential signaling pathways allowing entry, progression and exit of mitosis. The limiting step is thought to be the activation of the mitotic Cdk1-cyclin B kinase. However, this model has recently evolved with new data showing that in addition to the Cdk1-cyclin B complex, Greatwall (Gwl) kinase is also required to enter into and maintain mitosis. This new concept proposes that entry into mitosis is now based on the combined activation of both kinases Cdk1-cyclin B and Gwl, the former promoting massive phosphorylation of mitotic substrates and the latter inhibiting PP2A-B55 phosphatase responsible for dephosphorylation of these substrates. Activated Gwl phosphorylates both Arpp19 and ENSA, which associate and inhibit PP2A-B55. This pathway seems relatively well conserved from yeast to humans, although some differences appear based on models or techniques used. While Gwl is activated by phosphorylation, its inactivation requires dephosphorylation of critical residues. Several phosphatases such as PP1, PP2A-B55 and FCP1 are required to control the dephosphorylation and inactivation of Gwl and a properly regulated mitotic exit. Gwl has also been reported to be involved in cancer processes and DNA damage recovery. These new findings support the idea that the Gwl-Arpp19/ENSA-PP2A-B55 pathway is essential to achieve an efficient division of cells and to maintain genomic stability.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27759153     DOI: 10.1387/ijdb.160155tl

Source DB:  PubMed          Journal:  Int J Dev Biol        ISSN: 0214-6282            Impact factor:   2.203


  11 in total

1.  Cycling through mammalian meiosis: B-type cyclins in oocytes.

Authors:  Nora Bouftas; Katja Wassmann
Journal:  Cell Cycle       Date:  2019-06-23       Impact factor: 4.534

2.  MASTL is enriched in cancerous and pluripotent stem cells and influences OCT1/OCT4 levels.

Authors:  Elisa Närvä; Maria E Taskinen; Sergio Lilla; Aleksi Isomursu; Mika Pietilä; Jere Weltner; Jorma Isola; Harri Sihto; Heikki Joensuu; Sara Zanivan; Jim Norman; Johanna Ivaska
Journal:  iScience       Date:  2022-05-25

3.  Therapeutic natural compounds Enzastaurin and Palbociclib inhibit MASTL kinase activity preventing breast cancer cell proliferation.

Authors:  Aneesha Polisety; Gauri Misra; Jyotika Rajawat; Amit Katiyar; Harpreet Singh; Anant Narayan Bhatt
Journal:  Med Oncol       Date:  2022-05-23       Impact factor: 3.738

4.  The greatwall kinase is dominant over PKA in controlling the antagonistic function of ARPP19 in Xenopus oocytes.

Authors:  Aude-Isabelle Dupré; Olivier Haccard; Catherine Jessus
Journal:  Cell Cycle       Date:  2017-07-19       Impact factor: 4.534

5.  Ensa controls S-phase length by modulating Treslin levels.

Authors:  Sophie Charrasse; Aicha Gharbi-Ayachi; Andrew Burgess; Jorge Vera; Khaled Hached; Peggy Raynaud; Etienne Schwob; Thierry Lorca; Anna Castro
Journal:  Nat Commun       Date:  2017-08-08       Impact factor: 14.919

6.  TORC1 coordinates the conversion of Sic1 from a target to an inhibitor of cyclin-CDK-Cks1.

Authors:  Marta Moreno-Torres; Malika Jaquenoud; Marie-Pierre Péli-Gulli; Raffaele Nicastro; Claudio De Virgilio
Journal:  Cell Discov       Date:  2017-05-02       Impact factor: 10.849

7.  MASTL promotes cell contractility and motility through kinase-independent signaling.

Authors:  Maria Emilia Taskinen; Elisa Närvä; James R W Conway; Laura Soto Hinojosa; Sergio Lilla; Anja Mai; Nicola De Franceschi; Laura L Elo; Robert Grosse; Sara Zanivan; Jim C Norman; Johanna Ivaska
Journal:  J Cell Biol       Date:  2020-06-01       Impact factor: 10.539

Review 8.  Activating embryonic development in Drosophila.

Authors:  Emir E Avilés-Pagán; Terry L Orr-Weaver
Journal:  Semin Cell Dev Biol       Date:  2018-02-21       Impact factor: 7.727

Review 9.  PP2A-B55 Holoenzyme Regulation and Cancer.

Authors:  Perrine Goguet-Rubio; Priya Amin; Sushil Awal; Suzanne Vigneron; Sophie Charrasse; Francisca Mechali; Jean Claude Labbé; Thierry Lorca; Anna Castro
Journal:  Biomolecules       Date:  2020-11-22

10.  The Cell Cycle Checkpoint System MAST(L)-ENSA/ARPP19-PP2A is Targeted by cAMP/PKA and cGMP/PKG in Anucleate Human Platelets.

Authors:  Elena J Kumm; Oliver Pagel; Stepan Gambaryan; Ulrich Walter; René P Zahedi; Albert Smolenski; Kerstin Jurk
Journal:  Cells       Date:  2020-02-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.